In 2004, Prof. Dr. Dr. Markus Depfenhart completed his medical studies and received his doctorate from the JWG University in Frankfurt am Main in 2005. He later underwent further studies in other subjects. He now also holds an LL.M. in Economic Law and a Ph.D. in business and economics. Among other things, he developed an algorithm for legal patent circumvention. After numerous theoretical and practical training courses, he qualified as a board-certified emergency physician in 2008. He worked as an emergency physician in Hamburg, but also in crisis regions such as the Balkans and Afghanistan. Since 2014, he has been a board-certified specialist in plastic and aesthetic surgery. Due to numerous stays abroad, Markus Depfenhart can demonstrate international experience in various specialties. He is also constantly educating himself in this country. He is also an expert in skin and skincare-related topics, and his major focus is now peptide and protein design. In 2018 Markus Depfenhart was appointed as a professor of aesthetic and regenerative medicine at the Venlo University/ NL. Since 2020 he is also lecturing at the FOM University of Applied Science in Hamburg/ Germany. He also works as a consultant for the industry. What's more, he has a seat on the advisory board of various national and international companies. He is currently a member of the board of Lavenir Bioscience AG (Hamburg) and the Optiphi AG (Switzerland). Prof. Dr. Dr. Markus Depfenhart holds more than 30 patents and patent applications in different fields. Additionally, Prof. Dr. Dr. Markus Depfenhart is an extraordinary Professor at the NWU and WSU and he is currently leading the development of a new DNA-based vaccine platform at these two universities.